ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
10 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: PhRMA Foundation Assessing the Benefits of Treating Cancer Research Starter Grant
Opening Date: March 2014
Closing Date: May 16, 2014
Anticipated Award Date: July 2014
Researchers and clinicians have made remarkable progress in the fight against cancer, and death rates are falling. However, the disease still causes enormous suffering and represents a substantial economic burden in the United States. While cancer medicines have extended millions of lives and offer trillions in societal benefits, this value often is not well understood or fully characterized. Social and economic benefits accrue across a range of direct and indirect effects (e.g., overall survival, quality of life, and productivity) and evolve over time as the body of evidence and standards of practice change. As our understanding of the basic science of cancer grows, and this understanding is translated into novel diagnostics and treatments, patients and society benefit from continual innovation in cancer care. The purpose of this RFP is to encourage research aimed at quantifying the benefits to society that have accrued from innovations in cancer treatment.
The grant will be awarded to candidates who establish a sound and innovative research project focused on developing a novel way of quantifying or describing the social, patient-centered, and economic benefits of innovation in cancer treatment. Relevant research goals may include developing new methods to define and measure the societal benefits from cancer care innovation (for example, contributing to an understanding of value across a wider range of outputs that can be more difficult to assess, capturing heterogeneity in patient values (such as quality of life, productivity, etc.) within and among populations, and accounting for variability in value over time and its relationship to long-term aggregate clinical gains against cancer). Examples of the types of research questions of interest include:
-- Developing a novel way of describing the benefits of treatments that accrue over time as clinicians develop a better understanding of the disease process and treatment protocols. Oftentimes, patients who are enrolled in clinical trials are in later stages of the disease; however, once a drug is approved, it may be used at an earlier stage. Thus, the benefits of treatment may not be fully realized for several years after approval.
-- Describing improvements in quality of life, productivity, or other patient-centered measures that can result from cancer treatment. Patients may value certain outcomes and benefits differently than other stakeholders; describing the heterogeneity of value across the range of stakeholders (including patients, caregivers, providers, etc) is an important step to developing a fuller picture of treatment gains beyond the traditionally reported 5- and 10-year survival rates.
-- Building a more complete picture of innovation in cancer research and treatment over time. Most scientific progress builds on earlier research and development. Scientific understanding of cancer has grown from viewing the condition as a single monolithic disease to a constellation of hundreds of different molecular pathways. As scientists elucidate these pathways, there are spillover benefits as this increased understanding of the molecular basis of disease can result in advances in other areas.
This award is not intended for clinical or bench research, and is focused on supporting research in the health economics and social science fields. Additionally, research results should be generalizable to the U.S. context. Proposals focused on methods are eligible; however, researchers must clearly indicate how these new methods will be used to capture patient, population, or societal outcomes and benefits.
Individuals holding a rank of instructor, assistant professor, or investigator at the doctoral level are eligible to apply for a research starter grant. The program is not intended for individuals in post-doctoral training programs.
Applicants must be sponsored by the department within which the proposed research is to be undertaken. Applicants must be based in an academic, healthcare, or other research institution (e.g., schools of medicine, public health, pharmacy, nursing, etc) and should have the skills and experience required to carry out the proposed work. Applications are to be submitted to firstname.lastname@example.org and received by May 16, 2014.
The award consists of $100,000 support for one year and is made to the university or institution on behalf of the recipient, with the understanding that the university or institution will administer the funds. The “starter” aspect of the program strives to assist individuals who are establishing careers as independent investigators with an interest in describing the benefits of cancer treatment, innovation, and progress. The funds are to be used to conduct the proposed research and provide the grantee financial support to promote future research efforts in this field. Applicants are highly encourage to seek other funds to continue research following termination of the starter grant.
Recommended guidelines for using the starter grant funds are listed below. The submitted line item budget must reflect how the funds will be used based on the guidelines:
1. The purchase data or equipment that will support the proposed research efforts.
2. The support technical assistance (e.g., technician/research assistant; not including fringe benefits).
3. No more than $1,000 may be used per year for travel to professional meetings by the grantee.
4. A percentage of the funds may be used for salary (not to exceed 25%), if the review panel determines this level of support is justified given the applicant’s current position, current funding level, and proposed research plan.
5. The program provides no other subsidies (tuition, fringe benefits, indirect institutional costs, etc).
The applicant should also identify other intramural support presently available for the proposed project and other research efforts by budget categories and amounts. If the institution makes available the services of a technician or assistant to the candidate, please note this support. Other principals involved in the project as collaborators and the amount of time developed to the project by the applicant and other principals should also be identified. Please also list by titles the funded research project of each principal, the percentage of time committed, and the amount and source of funds for these projects. Additional investigators are welcome to as collaborators in a multidisciplinary research team. The amount of time to be devoted to the project by the applicant and other co-investigators or co-applicants should be clearly described in the research proposal.
A progress report (approximately 2 pages) will be required at midterm, and a final report (approximately 10 pages) will be required upon completion of the work. The PhRMA Foundation project officer should be made aware of manuscripts to be published as a result of the proposed research. The funds are non-transferrable.
The application package must be submitted in the order listed below as a single PDF. The applicant’s name, institution, and project title should be provided as a header on the top right corner of each page. Any questions about the application or eligibility criteria should be directed to Clara Soh at email@example.com.
List of Application Components:
1. Introduction page, including applicant name, mentor name, institution, project title, and research abstract (300 word limit)
2. Applicant CV or biosketch
3. 1-page applicant cover letter describing why he/she is qualified to conduct the proposed research and how the fellowship award will provide training and education to help further his/her career. The letter should also state whether the applicant has any conflicts of interest.
4. Research plan (10 page limit, 12 point font; single spaced, with 1” margins, bibliography excluded from page limit restriction) that includes a brief abstract and comprehensive description of the research plan. Applicants are requested to include a description of the study objective(s), conceptual framework, rationale, key measures, methodology, known limitations, expected findings, and significance/potential impact of the findings. Preliminary results, if any, should also be included. The proposal should state plans for dissemination of research findings (i.e., expected peer-reviewed publications, poster, or paper presentation at research meetings).
5. Budget, with breakdown of how funds will be used and any other anticipated sources of funding
6. Reprints of relevant articles published or co-authored by applicant
7. Contact information and CV/biosketch of applicant’s mentor/dissertation chair
8. Letter of recommendation from mentor/dissertation chair (1 page limit). The proposed research should be directed under the guidance of a mentor. The mentor must provide a letter of recommendation that certifies that formal mentorship will be available to ensure adequate training of the applicant and encourage progression of the study. The letter should also describe why the applicant’s potential and experience qualifies them to conduct the proposed research. The research record of the mentor and a description of how the mentored experience will enhance the applicant’s research objective(s) should also be included. The letter should describe how often and in what setting the mentor will engage with applicant (e.g., weekly meetings). The letter should also state whether the mentor has any conflicts of interest related to the proposed research. No more than one letter of recommendation is required or permitted.
Review Process and Criteria
Applications will be judged on the scientific worthiness of the proposed research and will be evaluated by a panel of qualified reviewers selected by the PhRMA Foundation. Reviewers may offer written critiques or suggestions of the proposal; award recipients are expected to incorporate reviewer feedback into their research. The review criteria will include the following (weight included in parenthesis):
-- Potential impact of research findings (20%)
-- Study approach and methodology (20%)
-- Innovativeness (20%)
-- Potential to stimulate further downstream research (15%)
-- Research environment/mentorship (10%)
-- Generalizability (10%)
-- Feasibility (5%)
Call for Applications: Livestrong Foundation Big C Competition
We're looking for big thinkers to create tangible innovations and solutions improving the daily lives of people facing cancer.
The Big C competition is an opportunity to change the way the world fights cancer.
How it Work
May 15 deadline for submitting your product, service or innovation.
150 semi-finalists have access to mentoring, crowdfunding and media exposure.
Five teams pitch in Austin for a chance to win $25,000!
(60 teams win a total of $140,000)
Solutions We Seek
The Big C competition invites you to submit projects addressing the following needs.
Rebuild Financial Health
Regain Emotional Wellbeing
Care for Caregivers
Improve Access to Quality Care
Fill the Knowledge Gap
Help Anyone Facing Cancer Now
Call for Applications: Sigma Theta Tau International/Hill-Rom Environment of Elder Care Nursing Research Grant
The Environment of Elder Care Nursing Research Grant co-sponsored by Hill-Rom will advance the science of nursing through research focused on critical aspects of elder care including clear lungs, no falls, safe skin, patient comfort and ease-of-use. Applications from novice researchers who have received no other national research funds are encouraged. Preference will be given to Sigma Theta Tau International members, other qualifications being equal.
Funds for this grant are provided by Hill-Rom. Allocation of funds is based on the quality of the proposed research, the future promise of the applicant and the applicant's research budget.
Funds for this grant do not cover expenses incurred prior to the funding date.
Registered nurse with a current license.
Hold at minimum a master's degree or its equivalent, and/or be enrolled in a doctoral program.
Submission of completed research application packet and a signed research agreement via our online submission system.
Ready to implement research project when funding is received.
Submit to STTI a final report; submit completed abstract to STTI's Virginia Henderson Global Nursing e-Repository.
Submit an abstract for publication to Hill-Rom regarding the research done as a product of the grant, and credit research grant partners in all publications and presentations of the research.
Grants available: 1 per year
Funding: up to US $9,000
Deadline: 1 July 2014
Funding date: 1 November 2014
Sigma Theta Tau International
Phone: 888.634.7575 (US/Canada) or +1.317.634.8171(International)
How to apply: All applications must be submitted via the online submission system.
Call for Applications: Sigma Theta Tau International/Hospice and Palliative Nurses Foundation End of Life Nursing Care Research Grant
The purpose of the Sigma Theta Tau International/Hospice and Palliative Nurses Foundation End of Life Nursing Care research grant is to encourage qualified nurses to contribute to the advancement of nursing care through research. Proposals for pilot and/or developmental research may be submitted for the grant.
Funds for this grant are provided jointly by Hospice and Palliative Nurses Foundation End of Life Nursing Care and Sigma Theta Tau International.
Registered nurse with current license
Hold a master’s or doctoral degree or be enrolled in a doctoral program
Submit a completed research application via online submission system
Ready to implement research project when funding is received
Complete project within one (1) year of funding
Sign a Research Grant Agreement
Submit a final report
Submit completed abstract to the Virginia Henderson Global Nursing e-Repository and credit research grant partner in all publications and presentations of the research.
Preference will be given to Sigma Theta Tau International and/or Hospice and Palliative Nurses Foundation End of Life Nursing Care members, other qualifications being equal.
Grants available: 1 per year
Deadline: 1 April 2014
Funding date: 1 August 2014
Sigma Theta Tau International
Phone: 888.634.7575 (US/Canada) or +1.317.634.8171(international)
How to apply:
All applications must be submitted via the online submission system.
Call for Applications: Neilsen Foundation’s Psychosocial Research Grants
The Craig H. Neilsen Foundation is the largest private foundation dedicated to spinal cord injury (SCI) research and quality of life programs for people living with SCI.
The Neilsen Psychosocial Research Grant cycle is now open to eligible organizations that conduct research on the interrelation of psychological, social and other quality of life factors that will benefit individuals living with SCI. The Foundation is specifically interested in research that focuses on one, or more, of the following areas: Aging, Caregiving, Employment, Health Behaviors and Fitness, Independent Living, Self-Management and Technology Access.
The overall goal for these grants is to lead to “better outcomes for people living with SCI.” Psychosocial research topics can address persons with SCI across the lifespan, including targeted SCI population subgroups or specific aspects of psychological and social support factors that impact health, functioning or quality of life. Research can involve qualitative and/or quantitative methodologies.
Interested applicants are encouraged to review the grant application guide, available at www.chnfoundation.org, for more details. The Neilsen Psychosocial Research Grant application process begins with submitting a required Letter of Intent (LOI) online by March 14, 2014 at 5:00 pm (Eastern Time).
The Neilsen Psychosocial Research Grants program has 3 funding categories:
~ NEILSEN POSTDOCTORAL FELLOWSHIP GRANTS: For individuals with a PhD, MD, DVM or comparable research degree that was attained prior to the LOI submission deadline of March 14, 2014. These grants are intended to provide mentored psychosocial research training in SCI. These grants provide two years of funding at $75,000 per year (for a total of $150,000).
~ NEILSEN PILOT GRANTS: For independent junior investigators beyond the postdoctoral level (i.e., Instructor, Assistant Professor or equivalent research position) or for psychosocial research projects that are considered “high risk/high gain,” conducted by junior or established investigators. These grants provide one year of funding, up to $100,000.
~ NEILSEN PROOF OF CONCEPT GRANTS: For established investigators (i.e., at the level of Associate Professor or above) to open new areas of SCI psychosocial research or fill important gaps in the SCI field. These grants provide two years of funding at $150,000 per year (for a total of $300,000).
Awarded grants will be funded in early 2015.
All three Neilsen Psychosocial Research grant funding categories require an online Letter of Intent (LOI) submission by March 14, 2014. LOIs will be reviewed and only those applicants invited through the LOI process may submit a full grant application.
The following general eligibility requirements apply to all three funding categories:
1. Applicants must work in a nonprofit academic institution, research organization/institution or rehabilitation facility with a demonstrated capability to conduct grant funded research. An applicant is not required to be a citizen of the United States or Canada to apply for a Neilsen Foundation research grant; however, the applicant must be employed by an eligible organization/institution located in either country (see item 2 for additional information). Each application must include the appropriate endorsement of an official who is responsible for the administration of awarded funds.
2. Applying organizations/institutions must be located in the United States or Canada. Neilsen Foundation research grants are not awarded to individuals, private foundations or certain 509(a)(3), Type III supporting organizations.
3. Applicants must have a PhD, MD, DVM or other equivalent professional degree at the time of the LOI submission. The Neilsen Foundation does not provide grants to undergraduate or predoctoral students. Proof of Concept Grant applicants should have a proven track record of psychosocial research and spinal cord injury experience.
4. The Neilsen Foundation discourages concurrent applications with overlapping aims from Postdoctoral Fellows and their mentor/sponsor(s) on multiple funding categories of this grant program.
For more details on eligibility requirements, please review the Neilsen Psychosocial Research Grants Application Guide, located at www.chnfoundation.org.
Interested applicants are encouraged to carefully review the Neilsen Psychosocial Research Grants Application Guide, located at www.chnfoundation.org. The application process begins with submitting a required Letter of Intent (LOI) online by March 14, 2014 at 5:00 pm (Eastern Time).
Call for Entries: Epilepsy Therapy Project 2014 Shark Tank Competition
The Epilepsy Therapy Project, an initiative of the Epilepsy Foundation, is inviting entries that represent the most innovative new ideas in epilepsy treatment and care for its third annual Shark Tank Competition. The winner(s) of the 2014 Shark Tank Competition will receive international recognition and compete for awards totaling $200,000 to support the development and commercialization of an important new product, technology or therapeutic concept to help people with epilepsy.
The deadline for submitting a Letter of Intent (LOI) is Friday, March 14, 2014. The Shark Tank review committee will select as many as five finalists. All finalists will be invited to present their product concepts or candidates at the 2014 Epilepsy Pipeline Update Conference, scheduled from June 5-7. The winning entry will be selected by a panel of judges representing physicians and scientists, corporate executives, leading industry investors, people with epilepsy and their family members. The project deemed to be the most innovative will be announced at the conference, and the winner(s) can receive as much as $200,000 to accelerate the idea towards improving the quality of life of people with epilepsy. All finalists are eligible for a travel stipend to attend the conference and free conference registration.
Examples of novel concepts:
■ a drug or device treatent that stops a seizure (especially those already developed or approved for a different indication)
■ a system that helps patients manage their treatment or their epilepsy (less invasive, less costly anti-epileptic drug measurement, for example)
■ a device that prevents personal injury from a seizure
■ any other concept that could improve the lives of people with epilepsy potentially in the near future
LOI Applications due Friday, March 14, 2014
The proposal must include information about intellectual property, and a brief development outline with milestones for deliverables. Explain the potential impact on people with epilepsy in terms of the creativity/ingenuity of the concept, as well as significance of this concept as an advancement for people with epilepsy.
■ Applicants must demonstrate an ability to move the proposed plan to completion, showing how the prize can accelerate any step along the path to market.
■ Inventors who submitted ideas for the 2012 or 2013 Shark Tank Competition are encouraged to re-submit their ideas if substantial progress has been made.
■ Applicants may reside in any country. No specific background or experience is required.
Address questions to firstname.lastname@example.org.
Scleroderma Foundation Research Grant Funding Program
The grant application deadline is 5 p.m. Eastern Sept. 15 each year. (Note: If the grant deadline falls on a weekend, the following Monday will be the deadline.)
Appropriate Areas of Research and Criteria
Appropriate research areas may include but are not limited to the following as they relate to scleroderma:
Studies of animal models.
Mechanisms of end organ damage.
Endothelial cell biology.
Models and markers of gender and genetic factors.
Stem cell biology.
Health services research (e.g. quality of life, health care delivery.)
Study of clinical manifestation.
Call for Applications: Massage Therapy Foundation Community Service Grants
The deadline is Tuesday, April 1, 2014.
Community Service grants are awarded to charitable organizations that provide massage therapy to people who currently have little or no access to such services.
This program is designed to promote working partnerships between the massage therapy profession and community-based organizations.
The maximum award is $5,000 for a one-year project period. These grants are available for organizations or affiliates of organizations that have been in existence for at least one year in the respective state or province; are tax-exempt under schedule 501(c)(3) in the U.S., non-profit charitable organization in other countries; currently provide some therapeutic or other service programs to the community; and have designated a qualified staff member to oversee the program.
Contact Gini Ohlson, Executive Director at email@example.com or 847-905-1520.
M. Powell Lawton Distinguished Contribution Award for Applied Gerontology
The Retirement Research Fund Distinguished Contribution Award in Applied Gerontology is presented in honor of the memory of M. Powell Lawton to recognize those whose contributions have improved the quality of life of older persons.
Annual deadline: March 15
The Distinguished Contribution Award in Applied Gerontology is presented in honor of the memory of M. Powell Lawton to recognize those whose contributions have improved the quality of life of older persons. The contributions being honored include developing or implementing a program, practice, policy, or treatment that has had or will have the great potential to improve the lives of older adults.
The recipient will be presented with a plaque and a cash award of $1,500 at the Division 20 Business Meeting during the annual APA convention in the year the award is received.
Nomination materials should be sent in one email to the Chair of the Awards Committee, with "D20 Lawton Award Nomination" noted as the subject of the email by March 15 annually. The nomination materials will include the following:
A letter of nomination (by a Division 20 member) describing the nominee's nature and significance of the nominee's research accomplishments.
A current CV of the nominee.
Evidence of the positive impact of the contribution(s) on older persons.
A brief statement by the nominee of his or her current work and future plans.
At least two additional letters of support (one must be from a Division 20 member).
Nominees need not be members of Division 20, but they must be nominated and endorsed by a Division member.
How to Apply
Nominees will be reviewed by a committee of past-presidents, as well as past and present members of the Division Executive Committee.
Solomon Carter Fuller Award
Named after Dr. Solomon Carter Fuller, recognized as the first Black psychiatrist in American, the Fuller award honors a Black citizen who has pioneered in an area which has significantly benefited the quality of life for Black people.
The award recipient receives a plaque and a $500 honorarium upon presentation of the award lecture at the APA Annual Meeting or the Institute on Psychiatric Services.
Nominees for the award must be of African descent.
A nomination consists of a letter summarizing how and why the nominee is deserving of the award, a one-page biographical sketch of the nominee, and the nominee’s curriculum vitae. Nominations must be submitted electronically at firstname.lastname@example.org.
Deadline: June 1
Selection is made by a work group of the APA Council on Minority Mental Health and Mental Health Disparities consisting of a representative from the Council and the officers of the Caucus of Black Psychiatrists.